Sergio Fazio
10PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 01, 2025
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome.Sotirios Tsimikas, Michael Szarek, Christa M Cobbaert
|Sep 25, 2025
Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy.Esther Reijnders, Patrick M Bossuyt, J Wouter Jukema
|Aug 23, 2025
Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial.Gregory P Geba, Kusha A Mohammadi, Amy Damask
|Jul 03, 2025
LDL-Bound PCSK9 Has a Slower Clearance Kinetic and Higher Use for HSPGs Than Free-PCSK9-Brief Report.Silvia Cecilia Pacheco-Velázquez, Carlota Oleaga, Bastian Ramms
|Apr 07, 2025
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES.P Gabriel Steg, Michael Szarek, J Wouter Jukema
|Aug 26, 2023
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests.Michael Szarek, Esther Reijnders, J Wouter Jukema
Pageof 2
Frequent Collaborators
6 joint publications
Michael Szarek
6 joint publications
Philippe Gabriel Steg
6 joint publications
Gregory Schwartz
5 joint publications
Deepak L Bhatt
5 joint publications
Vera Bittner
4 joint publications
Harvey White
4 joint publications
Shaun Goodman
4 joint publications
J Wouter Jukema
3 joint publications
Rafael Diaz
3 joint publications
Paul A Mueller
